(Mealey's) The European Medicines Agency (EMA) on Sept. 23 recommended that the marketing authorization for GlaxoSmithKline PLC's (GSK) controversial anti-diabetes drug Avandia be suspended, and the Food and Drug Administration simultaneously... Read More
PHILADELPHIA — (Mealey’s) Two attorneys have settled their Avandia personal injury cases in federal and state courts with defendant GlaxoSmithKline plc, a source told Mealey Publications May 10. According to the source, W. Mark Lanier of... Read More